• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

pharma CEO

Headshot of Lundbecks CEO Charl van Zyl
Pharma

How Lundbeck’s CEO aims to keep firm ‘punching above its weight’

Lundbeck’s CEO, Charl van Zyl, told Fierce that he is confident the company can prove its mettle as a “neuroscience challenger.”
Fraiser Kansteiner Aug 21, 2026 11:30am
Sanofi headquarters Sanofi

New CEO Garijo sketches out vision to redirect Sanofi's fortunes

Jul 30, 2026 11:18am
Narasimhan

Novartis CEO shrugs off oral PCSK9 threat amid Q2 growth

Jul 21, 2026 10:36am
Four large while puzzle pieces are being connected together on a dark brown table by four sets of hands

Merck KGaA charts biggest deal in 10+ years with Bio-Techne buy

Jun 25, 2026 9:56am
Astellas

Inside Astellas CEO's plan to counter Xtandi's patent cliff

Jun 11, 2026 6:00pm
Mike Doustdar Novo Nordisk Novo Novo CEO

Novo Nordisk’s ‘optimistic’ CEO Doustdar sits down with Fierce

Jun 11, 2026 7:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings